Fundz

Duality Technologies Inc. reported raising $30 Million in an amended SEC Form D filing, from an offering of $30 Million

PRIVATEOct 07, 2021

Amount Raised

$30 Million

$30 Million sold, per SEC Form D (first sale Oct 7, 2021)

Round Type

Venture

San FranciscoBiotechnologyresearch

Quick answer

Dualitas Therapeutics raised $30 Million in a funding round, dated October 7, 2021. Dualitas Therapeutics is based in San Francisco, California, United States.

How much did Dualitas Therapeutics raise?
Dualitas Therapeutics raised $30 Million in a funding round on October 7, 2021.
What does Dualitas Therapeutics do?
Dualitas Therapeutics is a biotechnology company pioneering the future of bispecific antibody therapies for immune and inflammatory (I&I) diseases and beyond.
Where is Dualitas Therapeutics based and how big is it?
Dualitas Therapeutics is based in San Francisco, California, United States. Fundz records about 16 employees.
Who are the decision-makers at Dualitas Therapeutics?
Fundz holds 1 contact at Dualitas Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in research and Biotechnology around the same time

Companies in the same sectors as Dualitas Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • Metallomix raised $300K on November 17, 2021.
  • Metallomix raised $1.2M on October 18, 2021.
  • Nusano raised $48M on September 23, 2021.
  • Aarvik Therapeutics raised $8.3M on September 2, 2021.
  • Linnaeus Therapeutics raised $4.3M (Seed) on August 24, 2021.
  • Helaina Inc raised $20M (Series A) on November 19, 2021.

Who to call at Dualitas Therapeutics, and when

A new round usually means Dualitas Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Dualitas Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Dualitas Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Dualitas Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Dualitas Therapeutics

Location

681 Gateway Boulevard Suite 411

San Francisco, California, United States

About

Dualitas Therapeutics is a biotechnology company pioneering the future of bispecific antibody therapies for immune and inflammatory (I&I) diseases and beyond. Powered by our proprietary DualScreen™ discovery engine and a growing library of novel cell surface proximity engagers, our pipeline—including lead programs DTX-103 and DTX-102—has demonstrated compelling preclinical evidence supporting its potential to address important unmet patient needs. We offer partnering opportunities on the next generation of bispecific therapies in I&I diseases – and beyond.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Dualitas Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Dualitas Therapeutics's next move

See what Strategic adds

Dualitas Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.